Global Genomic Medicine Consortium (G2MC)
Convening communities, advancing implementation, improving health
G2MC is an international community formed to advance the implementation of genomic medicine and improve health for all.
It is our mission to leverage and nurture global expertise, create practical, real world solutions, and disseminate knowledge for implementing genomic medicine in diverse settings around the world.
FEATURED EVENT
7th G2MC International Conference, 2023
The Global Genomic Medicine Consortium (G2MC) 7th International Conference held October 2-4, 2023 in Geneva, Switzerland has concluded. A huge thank you to our speakers, sponsors, conference organizers, and attendees for making this a successful event! Read about the conference highlights and steps moving forward below.
HOW WE WORK




Functional Groups
- Resource Center Working Group
- Membership Working Group
- Implementation Projects Working Group
- Conference Planning Working Group (Ad Hoc)
Flagship Projects
GGMC Core Committees
- Workforce & Training Core Committee
- Policy Core Committee
- Diversity, Equity and Inclusion (DEI) Core Committee
OUR COMMUNITY
Connect and Collaborate. Create Implementation Opportunities. Contribute to Demonstration Projects.
Our community is comprised of health professionals, scientists, educators, and policy makers in over 35 countries. We collaborate to demonstrate the value and the effective use of genomics in medicine. Join us to share and learn best practices.

LATEST NEWS & EVENTS
-
Reporting from ASHG 2023: Day One
2023-11-13 -
2023 G2MC Post-Conference Update
2023-11-01
SUPPORT
Making an Impact
G2MC is an independent not-for-profit 501(c)(3) tax-exempt organization. Our mission to improve global health through the implementation of genomic tools and knowledge into health care delivery can only be advanced through the support of our sponsors and funders. Click below for more information on becoming a sponsor or providing a donation, including sponsorship benefit levels.
partners and funders


















